Complement receptor type 1
| GO Term | Evidence Code | Reference |
|---|---|---|
| positive regulation of activation of membrane attack complex | ||
| negative regulation of activation of membrane attack complex | ||
| organ or tissue specific immune response | ||
| complement receptor mediated signaling pathway | ||
| immune complex clearance |
| GO Term | Evidence Code | Reference |
|---|---|---|
| obsolete extracellular space |
|
|
| cytoskeleton | ||
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane |
| GO Term | Evidence Code | Reference |
|---|---|---|
| virus receptor activity |
|
|
| complement component C3b binding | ||
| complement component C4b binding | ||
| complement component C4b receptor activity | ||
| complement component C3b receptor activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 56 |
|
|
||
| 252 |
|
|
||
| 315 |
|
|||
| 410 |
|
|
||
| 447 |
|
|||
| 509 |
|
|
||
| 578 |
|
|||
| 702 |
|
|
||
| 860 |
|
|
||
| 897 |
|
| Pathway Name | Organism |
|---|---|
| Neutrophil degranulation | Homo sapiens |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | Homo sapiens |
| Regulation of Complement cascade | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:12365 | malaria |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026